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Abstract In the present study we have investigated the effect of
increased serine/threonine phosphorylation of insulin receptor
substrates-1 and -2 (IRS-1 and IRS-2) by okadaic acid
pretreatment on brown adipocyte insulin signalling leading to
glucose transport, an important metabolic effect of insulin in
brown adipose tissue. Okadaic acid pretreatment before insulin
stimulation decreased IRS-1 and IRS-2 tyrosine phosphorylation
in parallel to a decrease in their sodium dodecyl sulfate^
polyacrylamide gel electrophoresis mobility. IRS-1/IRS-2-asso-
ciated p85K and phosphatidylinositol (PI) 3-kinase enzymatic
activity were partly reduced in brown adipocytes pretreated with
okadaic acid upon stimulation with insulin. Furthermore, insulin-
induced glucose uptake was totally abolished by the inhibitor in
parallel with a total inhibition of insulin-induced protein kinase C
(PKC) j activity. However, activation of Akt/PKB or p70 S6
kinase (p70s6k) by insulin remained unaltered. Our results
suggest that downstream of PI 3-kinase, insulin signalling
diverges into at least two independent pathways through Akt/
PKB and PKC j, the PKC j pathway contributing to glucose
transport induced by insulin in fetal brown adipocytes.
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1. Introduction
Brown adipose tissue is the main tissue involved in non-
shivering thermogenesis in mammalian newborns and is re-
sponsible for heat production associated with the expression
of the mitochondrial uncoupling protein-1 (UCP1) [1]. Di¡er-
entiation of brown adipose tissue also encompasses an adipo-
genic program related to lipid synthesis and its accumulation
results in a multilocular fat droplets phenotype [2], with glu-
cose being the main lipogenic substrate [3,4]. Insulin promotes
glucose uptake into muscle and adipose tissues through trans-
location of the Glut4 glucose transporter from an intracellular
pool to the plasma membrane [5]. An impairment of the abil-
ity of insulin to stimulate glucose uptake in these tissues con-
tributes to the development of type 2 diabetes, hypertension
and cardiovascular disease [6]. Over the past two decades,
considerable progress has been made de¢ning the upstream
signaling mechanisms regulating insulin-induced glucose up-
take into the cells. It is well known that after insulin stimu-
lation, insulin receptor substrate-1 and -2 (IRS-1 and IRS-2)
are phosphorylated on several tyrosine residues, most of them
being located in YXXM or YMXM motifs [7,8]. This tyrosine
phosphorylation step is crucial, since it allows the interaction
of IRS proteins with SH2 domain-containing proteins leading
to the activation of multiple signalling pathways. Among
these, the activation of phosphatidylinositol 3-kinase (PI 3-
kinase) has been shown to be essential for insulin-induced
Glut4 translocation and glucose uptake [9^13]. Hence, abnor-
malities in these phosphorylations are likely to lead to alter-
ations in insulin action.
In addition to tyrosine, phosphorylation increased serine
and, to a lesser extent, threonine phosphorylation of either
the insulin receptor L-subunit or IRS-1 have been associated
with reduced insulin signalling, resulting in an insulin-resistant
state [14^18]. These results prompted us to investigate in our
cell model of brown adipocytes whether the elevation of ser-
ine/threonine phosphorylation of IRS-1 and IRS-2 by okadaic
acid, a serine/threonine phosphatase inhibitor, could interfere
with the signalling pathways emerging downstream of these
molecules. Furthermore, we analyzed the e¡ect of this inhib-
itor in insulin-induced glucose uptake, one of the main meta-
bolic e¡ects of this hormone in brown adipose tissue.
2. Materials and methods
2.1. Materials
Fetal calf serum (FCS) and culture media were from Imperial Lab-
oratories (Hampshire, UK). Insulin, okadaic acid and anti-mouse
IgG-agarose were from Sigma (St. Louis, MO, USA). Protein A-agar-
ose was from Roche Molecular Biochemicals. For IRS-1 and IRS-2
immunoprecipitations, polyclonal antibodies were the generous gift
of Dr. M.F. White (Joslin Diabetes Center, MA, USA). The anti-
insulin receptor L-subunit monoclonal antibody and the pY20 anti-
Tyr(P) antibody were purchased from Santa Cruz Biotechnology
(Palo Alto, CA, USA). The antibodies against Akt1 and Akt2 were
purchased from Upstate Biotechnology (Lake Placid, NY, USA). The
anti-phospho serine493 Akt, total Akt and anti-phospho serine424/
threonine421 p70s6k antibodies were purchased from New England
Biolabs (Beverly, MA, USA). The anti-protein kinase C (PKC)
j antibody was purchased from Gibco BRL (Life Technologies).
[Q-32P]ATP (3000 Ci/mmol) and 2-deoxy-D[1-3H]glucose (11.0 Ci/
mmol) were from Amersham (Aylesbury, UK). All other reagents
used were of the purest grade available.
2.2. Cell culture
Brown adipocytes were obtained from interscapular brown adipose
tissue of 20-day-old fetuses of Wistar rats and isolated by collagenase
dispersion as described [19]. Cells were plated at 5U106 cells/100 mm
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or 1^1.2U106 cells/60 mm tissue culture plates in MEM supplemented
with 10% FCS to allow cell attachment to the plastic surface of the
plates. After 4^6 h of culture at 37‡C, cells were rinsed twice with
phosphate bu¡ered saline (PBS) and 80% of the initial cells were
attached. Cells were maintained for 20 h in a serum-free medium
supplemented with 0.2% (w/v) bovine serum albumin (BSA) to assure
inhibition of the intrinsic mitogenic competence of fetal cells and
quiescence. At this time, cells were treated for 5 min with 10 nM
insulin, or preincubated for 30 min with 1 WM okadaic acid followed
by treatment for 5 min with 10 nM insulin, or in the absence of
growth factors as a control for cellular quiescence.
2.3. Immunoprecipitations
Quiescent fetal brown adipocytes (after 20 h of serum deprivation)
were treated with insulin or okadaic acid plus insulin in MEM as
indicated and lysed at 4‡C in bu¡er containing 10 mM Tris/HCl,
5 mM EDTA, 50 mM NaCl, 30 mM sodium pyrophosphate, 50
mM NaF, 100 WM Na3VO4, 1% Triton X-100 and 1 mM phenylmeth-
ylsulfonyl £uoride, pH 7.6 (lysis bu¡er). After protein content deter-
mination, equal amounts of protein were immunoprecipitated at 4‡C
with the corresponding antibodies and the immune complexes were
collected on protein A-agarose or antimouse Ig-agarose beads. Immu-
noprecipitates were washed three times with lysis bu¡er analyzed by
sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) followed by Western blotting as previously described [20].
2.4. In vitro autophosphorylation assay
The insulin receptor autophosphorylation was measured in vitro as
described [21]. The anti-Tyr(P) immune complexes were incubated in
kinase bu¡er containing 20 mM HEPES, 3 mM MnCl2, 10 mM
MgCl2, and 20 WCi of [Q-32P]ATP (in a ¢nal concentration of 5 mM)
for 15 min at room temperature. The complexes were washed twice
with cold PBS and then resuspended in 2U SDS^PAGE sample bu¡er
and analyzed by SDS^PAGE. The separated proteins were dried in
the gel and the incorporation of [32P]phosphate into proteins was
visualized by autoradiography and quantitated by scanning laser den-
sitometry (Molecular Dynamics).
2.5. PI 3-kinase activity
PI 3-kinase activity was measured in the anti-IRS-1 and anti-IRS-2
immunoprecipitates by in vitro phosphorylation of PI as described
[22].
2.6. PKC j activity
Fetal brown adipocytes either untreated or stimulated were ex-
tracted with lysis bu¡er (50 mM Tris, pH 7.5, 150 mM NaCl, 1%
Triton X-100, 2 mM EDTA, 1 mM EGTA, 1 WM PMSF, 25 Wg/ml
leupeptin and 25 Wg/ml aprotinin) and immunoprecipitated with an
anti-PKC j antiserum. Immune complexes were washed ¢ve times
with ice-cold lysis bu¡er with 0.5 M NaCl and two times with kinase
bu¡er (35 mM Tris, pH 7.5, 10 mM Mg Cl2, 0.5 mM EGTA, 1 WM
Na3VO4). The kinase reaction was performed in bu¡er containing
1 WCi of [Q-32P]ATP, 60 WM ATP and 1 Wg of MBP as a substrate
for 30 min at 30‡C and was terminated by the addition of 4U SDS^
PAGE sample bu¡er followed by boiling for 5 min at 95‡C. Samples
were resolved in 12% SDS^PAGE; and gels were dried out and sub-
jected to autoradiography.
2.7. Measurement of the glucose transport
Glucose transport was measured in triplicate dishes from three in-
dependent experiments as previously described [20].
2.8. Protein determination
Protein determination was performed by the Bradford dye method
[23], using the Bio-Rad reagent and BSA as the standard.
3. Results
3.1. E¡ect of okadaic acid on insulin-induced IRS-1, IRS-2 and
insulin receptor tyrosine phosphorylation in fetal brown
adipocytes
Insulin stimulates tyrosine phosphorylation of IRS-1/IRS-2
in primary fetal brown adipocytes at physiological doses [24].
Our ¢rst aim in this paper was to investigate whether serine/
threonine phosphorylations modulate the levels of tyrosine
phosphorylation of these IRS in fetal brown adipocyte pri-
mary cultures. Quiescent cells (20 h serum-deprived) were
stimulated for 5 min with 10 nM insulin or preincubated for
40 min with 1 WM okadaic acid, a serine/threonine phospha-
tase inhibitor, and subsequently stimulated with 10 nM insulin
for a further 5 min. Then, cell lysates were immunoprecipi-
tated with the corresponding antibodies against IRS-1 and
IRS-2 and the immune complexes were analyzed by Western
blot with the anti-Tyr(P) antibody. As shown in Fig. 1, in-
sulin-induced tyrosine phosphorylation of IRS-1 was signi¢-
Fig. 1. E¡ect of okadaic acid on insulin-induced tyrosine phosphorylation of IRS-1/2 and insulin receptor L-chain in fetal brown adipocytes.
Left panel: 20 h serum-starved fetal brown adipocytes were incubated for 5 min with 10 nM insulin or preincubated for 40 min with 1 WM
okadaic acid followed by treatment with 10 nM insulin for a further 5 min. Cells were then lysed and immunoprecipitates, prepared with anti-
IRS-1 and anti IRS-2 antibodies, were submitted to SDS^PAGE and analyzed by Western blotting with the anti-Tyr(P) antibody or with the
anti-IRS-1 and anti-IRS-2 antibodies. Right panel: cells were cultured as described above. The anti-Tyr(P) immunoprecipitates were assayed
for in vitro autophosphorylation or the anti-IR L-chain immunoprecipitates were analyzed by Western blotting with the anti-Tyr(P) antibody.
All the results shown are representative of at least three independent experiments.
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cantly reduced in cells pretreated with 1 WM okadaic acid as
compared with non-pretreated cells. Interestingly, a slight
shift in the electrophoretic mobility of IRS-1, which indicates
a serine/threonine phosphorylation [15], was observed in in-
sulin-stimulated cells that had been pretreated with the inhib-
itor. Insulin-induced tyrosine phosphorylation of IRS-2 was
also markedly reduced by okadaic acid pretreatment, the elec-
trophoretic mobility shift being slightly higher than that of
IRS-1. Furthermore, the reblotting of the membranes with
the corresponding anti-IRS-1 and anti-IRS-2 antibodies re-
vealed equal amounts of immunoprecipitated proteins under
all the experimental conditions.
To evaluate the e¡ect of okadaic acid pretreatment on ty-
rosine autophosphorylation of the insulin receptor L-subunit,
serum-deprived brown adipocytes were stimulated as de-
scribed above. Then, lysates were subjected to immunopreci-
pitation with the anti-Tyr(P) antibody and an in vitro assay of
insulin receptor autophosphorylation was performed. As
shown in Fig. 1, the presence of 10 nM insulin caused a
marked increase in the tyrosine autophosphorylation of the
95 kDa band, which corresponds with the Mr of the L-subunit
of the insulin receptor, little phosphorylation being observed
in control cells either in the absence or presence of okadaic
acid. The level of tyrosine phosphorylation of the 95 kDa
band did not change signi¢cantly when brown adipocytes
were pretreated with 1 WM okadaic acid before insulin stim-
ulation. The same results were obtained by direct immunopre-
cipitation with the anti-insulin receptor antibody followed by
Western blotting with the anti-Tyr(P) antibody.
3.2. E¡ect of okadaic acid on insulin-induced
IRS-1/IRS-2-associated p85K subunit and PI 3-kinase
activity in fetal brown adipocytes
Our next aim was to analyze the e¡ect of okadaic acid in
the insulin signalling downstream IRSs. In the case of the
brown adipocyte insulin/IGF-I receptor, PI 3-kinase is stimu-
lated by the interaction of the p85K regulatory subunit with
tyrosine-phosphorylated IRS-1 and IRS-2 [24]. To study
whether this interaction is a¡ected by okadaic acid, we pre-
pared soluble cell lysates after the incubation of cells in the
absence or presence of 1 WM okadaic acid before insulin (10
nM) stimulation, as described above. They were immunopre-
cipitated with the anti-IRS-1 and anti-IRS-2 antibodies and
analyzed by Western blotting with the anti-p85K antibody. As
shown in Fig. 2, control cells did not show any p85K bound to
either IRS-1 or IRS-2, regardless of the pretreatment with
okadaic acid. After an addition of 10 nM insulin for 5 min
there was a marked increase in the amount of p85K bound to
both IRS proteins. However, when cells were pretreated with
1 WM okadaic acid before the stimulation with insulin, there
was a signi¢cant reduction in the amount of p85K bound to
IRS-1 and IRS-2.
Next, we wanted to demonstrate if the reduction of the
amount of IRS-1/IRS-2-associated p85K subunit of PI 3-ki-
nase in the presence of okadaic acid had an e¡ect on the
activation of its enzymatic activity. As shown in Fig. 2 (bot-
tom), there was a signi¢cant inhibition of insulin-stimulated
IRS-1 and IRS-2-associated PI 3-kinase activity in cells that
Fig. 2. E¡ect of okadaic acid on the association of IRS-1 and IRS-2 with the p85K subunit of PI 3-kinase and PI 3-kinase activity in fetal
brown adipocytes. Upper panel: 20 h serum-starved fetal brown adipocytes were stimulated as described in Fig. 1. Cells were then lysed and
the anti-IRS-1 or anti-IRS-2 immunoprecipitates were analyzed by SDS^PAGE followed by Western blotting with the anti-p85K antibody. Rep-
resentative experiments are shown. Results are the mean þ S.E.M. (n = 3) from three independent experiments and are expressed as arbitrary
units of IRS-1/IRS-2-associated p85K. Statistical analysis by Student’s paired t-test between values in the presence of insulin plus okadaic acid
versus insulin is represented by an asterisk; *P6 0.01. Lower panel: quiescent fetal brown adipocytes were cultured as described above. The
immunoprecipitates (prepared with the anti-IRS-1 or anti-IRS-2 antibodies) were washed and immediately used for an in vitro PI 3-kinase as-
say. Results are expressed as arbitrary units of PI 3-kinase activity and are the mean þ S.E.M. (n = 3) from three independent experiments. Stat-
istical analysis by Student’s paired t-test between values in the presence of insulin plus okadaic acid versus insulin is represented by an asterisk;
*P6 0.01.
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have been pretreated with okadaic acid before insulin stimu-
lation.
3.3. E¡ect of okadaic acid on insulin-induced glucose transport
in brown adipocytes
PI 3-kinase has been implicated as one of the key signal
transducers in insulin/IGF-I-induced glucose uptake in brown
adipose tissue [25,26]. To determine the e¡ect of okadaic acid
on insulin-induced glucose transport, brown adipocytes were
pretreated with various doses (0.25^1 WM) of okadaic acid,
stimulated for 10 min with 10 nM insulin and then incubated
for a further 5 min in the presence of 2-deoxy-D[1-3H]glucose.
As shown in Table 1, okadaic acid inhibited insulin-induced
glucose transport in a dose-dependent manner. Interestingly,
total inhibition of insulin-induced glucose transport was eli-
cited at 1 WM okadaic acid concentration, which was the dose
that partly inhibited IRS-associated PI 3-kinase activity. Fur-
thermore, glucose transport of the control cells was reduced in
the presence of the serine phosphatase inhibitor.
3.4. Okadaic acid inhibits insulin-induced PKC j activation, but
not Akt or p70s6k activation, in fetal brown adipocytes
Finally, we examined whether Akt/PKB, p70s6k and the
atypical PKC j isoenzyme, downstream targets of PI 3-kinase,
act in the signalling pathway by which glucose transport is
activated upon insulin stimulation in brown adipocytes. Qui-
escent brown adipocytes were preincubated with okadaic acid
and subsequently stimulated with insulin as described above.
Cell lysates were analyzed by Western blotting with the total
Akt, the isoform-speci¢c and the anti-phospho Akt antibod-
ies. As shown in Fig. 3, okadaic acid alone increased Akt/
PKB phosphorylation in fetal brown adipocytes as compared
to control cells. Upon insulin stimulation, Akt/PKB was
highly serine phosphorylated, this e¡ect not being precluded
by the pretreatment with okadaic acid. In addition, the serine/
threonine phosphorylation of p70s6k in response to insulin,
determined by Western blotting with an anti-phospho p70s6k
antibody, remained una¡ected by the presence of the inhib-
itor.
The atypical PKC j isoenzyme is expressed in fetal brown
adipocytes and its enzymatic activity was analyzed in the anti-
PKC j immune complexes. As shown in Fig. 3, the level of
MBP phosphorylation in the presence of okadaic acid was
similar to that observed in non-treated brown adipocytes. In-
terestingly, PKC j activation induced in the presence of 10
nM insulin was inhibited by s 90% when okadaic acid was
present.
4. Discussion
Insulin resistance is a state in which target cells fail to
respond to ordinary levels of circulating insulin [27]. Previous
studies have reported that serine/threonine phosphorylation of
the insulin receptor itself by activation of PKC [28] and over-
expression of H-ras oncogen [18] resulted in a decreased ty-
rosine phosphorylation and insulin resistance. Furthermore
Fig. 3. E¡ect of okadaic acid on insulin-induced Akt, p70s6K and PKC j activation in fetal brown adipocytes. Left panel: quiescent brown adi-
pocytes were stimulated as described in Fig. 1. Cell lysates were analyzed by SDS^PAGE followed by Western blotting with the corresponding
antibodies against total Akt, Akt1, Akt2, phospho-Akt and phospho-p70s6k antibodies. Representative experiments are shown. Right panel:
cells were cultured as described above. Cell lysates were either analyzed by Western blotting with the anti-PKC j antibody or immunoprecipi-
tated with the anti-PKC j antibody and immediately assayed for PKC j activity. The corresponding autoradiograms were quantitated by scan-
ning densitometry. Results are expressed as arbitrary units of PKC j activity and are the mean þ S.E.M. (n = 3) from three independent experi-
ments. Statistical analysis by Student’s paired t-test between values in the presence of insulin plus okadaic acid versus insulin is represented by
an asterisk; *P6 0.01.
Table 1
Dose^response of okadaic acid on glucose transport in brown adi-
pocytes during insulin stimulation
Treatment None Insulin (10 nM)
None 2.20 þ 0.23 6.02 þ 0.74a
Okadaic acid (0.25 WM) 2.08 þ 0.82 4.51 þ 0.97
Okadaic acid (0.5 WM) 1.75 þ 0.36 2.65 þ 0.56b
Okadaic acid (1 WM) 1.33 þ 0.18 1.94 þ 0.12b
Brown adipocytes were stimulated as described in Fig. 1. Control
cells were incubated in serum-free medium. Deoxyglucose transport
was measured as described in Section 2. Results are the mean þ
S.E.M. (n = 3) from three independent experiments and are ex-
pressed as disintegrations/min/Wg of protein. Statistical analysis by
Student’s paired t-test between values in the presence of insulin ver-
sus control is represented by a and the di¡erences between values in
the presence of insulin plus okadaic acid versus insulin is repre-
sented by b. a;bP6 0.01.
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serine/threonine phosphorylation of IRS-1 by addition of the
serine/threonine phosphatase inhibitor okadaic acid [14], acti-
vation of cellular stress pathways by tumor necrosis factor K
(TNFK) [17] and more recently by activation of the MAP
kinase pathway [29] also resulted in a decreased tyrosine phos-
phorylation. These results, together with our previous pub-
lished data, prompted us to investigate in our cell model
whether the elevation of serine/threonine phosphorylation of
IRS-1 and IRS-2 upon okadaic acid pretreatment impairs in-
sulin signalling leading to glucose uptake in brown adipocytes.
The treatment of brown adipocytes with okadaic acid
markedly reduces the insulin stimulatory action on both
IRS-1 and IRS-2 tyrosine phosphorylation. In parallel, IRS-
1 and, to a greater extent, IRS-2 had a decreased electropho-
retic mobility in SDS^PAGE suggesting an increased phos-
phoserine/phosphothreonine content of these proteins. How-
ever, this insulin-resistant state occurs without detectable
changes in the insulin receptor L-subunit tyrosine kinase ac-
tivity. In comparison, TNFK pretreatment of brown adipo-
cytes, which led to insulin resistance on glucose transport
and also on the adipogenic-related gene expression, markedly
reduces the insulin receptor L-subunit tyrosine autophosphor-
ylation [30]. Thus, these results suggest that di¡erent phos-
phoserine/phosphothreonine elevating agents (i.e. okadaic
acid and TNFK) might have speci¢c targets within the brown
adipocyte signalling complex.
The activation of PI 3-kinase is an essential requirement for
complete brown adipocyte di¡erentiation [13]. The fact that
tyrosine phosphorylated IRS-1 and IRS-2 strongly associate
with and activate PI 3-kinase [24] indicates that both IRS
proteins equally contribute to propagating this signalling cas-
cade. In the present paper, we have shown that insulin-in-
duced IRS-1/IRS-2-association with p85K is signi¢cantly re-
duced by okadaic acid pretreatment. Consequently, these cells
showed a parallel inhibition of PI 3-kinase enzymatic activity.
These results indicate that the elevation of serine/threonine
phosphorylation of IRS-1/IRS-2, which decreases their tyro-
sine phosphorylation, impairs the PI 3-kinase signalling path-
way involved in brown adipocyte di¡erentiation. Interestingly,
inhibition of adipogenic di¡erentiation of brown adipocytes
with TNFK resulted in an inhibition of insulin-induced IRS-2-
associated PI 3-kinase activity, PI 3-kinase associated to IRS-
1 remaining unaltered [30]. Hence, IRS-1 and IRS-2 are sub-
jected to di¡erent phosphoserine/phosphothreonine negative
controls in brown adipocytes. Consequently, the speci¢c path-
ways which impair the insulin signalling cascade induced by
di¡erent phosphoserine/phosphothreonine elevating agents
merits further investigation.
It is well known that PI 3-kinase is required for the move-
ment of glucose transporters to the cell membrane in brown
adipose tissue [26] In fetal brown adipocytes, glucose trans-
port increased signi¢cantly upon stimulation with physiolog-
ical doses of insulin/IGF-I, this e¡ect being PI 3-kinase-de-
pendent [13,25]. However, controversial results of the role of
okadaic acid on insulin-induced glucose transport in adipose
cells have been published. An inhibitory e¡ect was proposed
in 3T3L1 adipocytes in parallel with a decreased IRS-1 tyro-
sine phosphorylation and PI 3-kinase activity [14]. In compar-
ison, okadaic acid provoked insulin-like e¡ects on glucose
transport and Glut4 translocation in rat white adipocytes
[31]. The pretreatment of brown adipocytes with okadaic
acid totally inhibited insulin-induced glucose uptake in a
dose-dependent manner, although 40^50% remnant PI 3-ki-
nase activity was found. These results prompted us to eluci-
date the PI 3-kinase downstream targets involved in glucose
uptake induced in response to insulin. Among these, the acti-
vation of PKC j, blunted by PI 3-kinase inhibitors [13], was
also inhibited by okadaic acid pretreatment. However, activa-
tion of other PI 3-kinase targets such as Akt/PKB or p70s6k
were not a¡ected by the inhibitor. In fact, although previous
reports indicate that transient expression of constitutive active
Akt/PKB results in the activation of GLUT4 translocation
[32,33], it seems that only a relatively small fraction of insu-
lin-stimulated GLUT4 translocation is inhibited by a kinase-
inactive form of Akt/PKB in rat adipocytes [33]. Also, studies
performed in 3T3L1 with a double mutant (T308AA, S473A)
as a dominant negative inhibitor, suggest that Akt/PKB is not
required for insulin-stimulated glucose transport [34]. Finally,
okadaic acid elicits insulin-like e¡ects and subsequently acti-
vates PKC j by itself in white adipocytes [35]. However, in
this paper we show that okadaic acid completely blocks in-
sulin-induced PKC j activity in parallel to glucose uptake in
brown adipocytes. Consequently, we propose the requirement
of the PI 3-kinase/PKC j pathway, but not the PI 3-kinase/
Akt pathway, for the insulin action on glucose uptake in
brown adipocytes.
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